To integrate the technology, BIDMC will utilise EchoSolv-AS on a no-cost basis while the Company pursues relevant reimbursement codes for users of the technology under insurance. Reimbursement codes are anticipated to be secured in the coming quarters, marking an important commercial milestone which when achieved will allow for first revenues to be recognised. [That is one of the more outrageously opaque timeframes I've seen in a while]
Literally zero added to the income stream.
I'm really surprised there hasn't been more discussion on here regarding the MC compared to revenue and future possible revenue. There are multiple companies on the ASX that have a lower MC, significantly higher revenue, and still have growth potential.
Not saying EIQ doesn't have growth potential. But would you really say "it's cheap"?
EIQ Price at posting:
24.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)